Schizophrenia Risk: DOC2A Gene Splicing Link Found

by Grace Chen

Kunming, China – january 16, 2024 – A newly discovered glitch in how our genes read instructions could be a key piece of the schizophrenia puzzle. Researchers have pinpointed a previously unknown role for choice splicing of the DOC2A gene in the advancement of the complex brain disorder.

Unlocking Schizophrenia’s Genetic Code: the Role of Splicing

This research sheds light on how subtle genetic variations can disrupt brain function, possibly opening doors to more targeted treatments for schizophrenia.

  • Researchers identified a previously undocumented protein form, DOC2A△Val217-Pro218, resulting from altered gene splicing.
  • Overexpression of this altered protein in mice led to behaviors mirroring schizophrenia, including anxiety and social withdrawal.
  • The findings emphasize the importance of considering protein isoforms-different versions of the same protein-in understanding complex diseases.

what causes schizophrenia? While genetics play a significant role, pinpointing the exact mechanisms has been challenging. Genome-wide studies have revealed thousands of genetic variants associated with the condition, but understanding how these variants contribute to the disease has remained elusive.

The research team, led by LI Ming from the Kunming Institute of Zoology of the Chinese Academy of Sciences, focused on a process called splicing.Think of RNA as a recipe for building proteins. Splicing is how the cell edits that recipe, cutting and pasting sections to create different versions-or isoforms-of the same protein. These isoforms can have distinct functions.

Using analyses of human postmortem brain tissue, the researchers identified more than 17,000 splicing quantitative trait loci (sQTLs) associated with schizophrenia. Among these, the SNP rs3935873 stood out as the strongest predictor of disrupted DOC2A splicing. Further examination revealed that this variant promotes the production of a truncated protein isoform, dubbed DOC2A△Val217-Pro218, which had never been documented before.

This previously unknown protein isoform appears to be a critical player in the development of schizophrenia-like behaviors, suggesting it could be a promising target for future therapies.

To test this, the team introduced the altered gene into mice. Remarkably, overexpression of the DOC2A△Val217-Pro218 isoform in the hippocampus-a brain region crucial for learning and memory-recapitulated behaviors associated with schizophrenia, including increased anxiety, impaired sensorimotor gating (difficulty filtering out irrelevant stimuli), and anhedonia (loss of interest or pleasure). These effects weren’t observed in control mice or those expressing the full-length DOC2A protein.

Further analysis revealed that the altered protein affects synaptic transmission-the way brain cells communicate-and disrupts specific molecular pathways, including those involving the myosin II complex. These changes suggest altered synaptic function, a hallmark of schizophrenia.

The study underscores the importance of alternative splicing in the genetic regulation of schizophrenia and provides a framework for investigating other unannotated protein isoforms that may contribute to the disease. By focusing on these isoform-specific mechanisms, researchers hope to develop more targeted and effective therapeutic strategies.

Have thoughts on this research? Share your comments below.

You may also like

Leave a Comment